Anti-SFXN3 monoclonal antibody

Pre-made anti-SFXN3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SFXN3/SFXN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1625-Ab-1/ GM-Tg-hg-IP1625-Ab-2Anti-Human SFXN3 monoclonal antibodyHuman
GM-Tg-rg-IP1625-Ab-1/ GM-Tg-rg-IP1625-Ab-2Anti-Rat SFXN3 monoclonal antibodyRat
GM-Tg-mg-IP1625-Ab-1/ GM-Tg-mg-IP1625-Ab-2Anti-Mouse SFXN3 monoclonal antibodyMouse
GM-Tg-cynog-IP1625-Ab-1/ GM-Tg-cynog-IP1625-Ab-2Anti-Cynomolgus/ Rhesus macaque SFXN3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1625-Ab-1/ GM-Tg-felg-IP1625-Ab-2Anti-Feline SFXN3 monoclonal antibodyFeline
GM-Tg-cang-IP1625-Ab-1/ GM-Tg-cang-IP1625-Ab-2Anti-Canine SFXN3 monoclonal antibodyCanine
GM-Tg-bovg-IP1625-Ab-1/ GM-Tg-bovg-IP1625-Ab-2Anti-Bovine SFXN3 monoclonal antibodyBovine
GM-Tg-equg-IP1625-Ab-1/ GM-Tg-equg-IP1625-Ab-2Anti-Equine SFXN3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1625-Ab-1/ GM-Tg-hg-IP1625-Ab-2; GM-Tg-rg-IP1625-Ab-1/ GM-Tg-rg-IP1625-Ab-2;
GM-Tg-mg-IP1625-Ab-1/ GM-Tg-mg-IP1625-Ab-2; GM-Tg-cynog-IP1625-Ab-1/ GM-Tg-cynog-IP1625-Ab-2;
GM-Tg-felg-IP1625-Ab-1/ GM-Tg-felg-IP1625-Ab-2; GM-Tg-cang-IP1625-Ab-1/ GM-Tg-cang-IP1625-Ab-2;
GM-Tg-bovg-IP1625-Ab-1/ GM-Tg-bovg-IP1625-Ab-2; GM-Tg-equg-IP1625-Ab-1/ GM-Tg-equg-IP1625-Ab-2
Products NameAnti-SFXN3 monoclonal antibody
Formatmab
Target NameSFXN3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SFXN3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1625-Ag-1Recombinant multi-species SFXN3/ BA108L7.2/ SFX3 protein
    ORF Viral VectorvGMLP003063human SFXN3 Lentivirus particle
    ORF Viral VectorpGMLP003063human SFXN3 Lentivirus plasmid
    ORF Viral VectorpGMLPm001947mouse Sfxn3 Lentivirus plasmid
    ORF Viral VectorvGMLPm001947mouse Sfxn3 Lentivirus particle


    Target information

    Target IDGM-IP1625
    Target NameSFXN3
    Gene ID81855,94280,65042,712607,486848,101094881,511755,100060384
    Gene Symbol and SynonymsBA108L7.2,SFX3,SFXN3,SLC56A3,SLC64A3,TCC
    Uniprot AccessionQ9BWM7,Q9JHY2,A6QP55
    Uniprot Entry NameSFXN3_HUMAN,SFXN3_RAT,SFXN3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000107819
    Target ClassificationN/A

    The target: SFXN3, gene name: SFXN3, also named as BA108L7.2, SFX3, SLC56A3. Enables serine transmembrane transporter activity. Involved in serine import into mitochondrion. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.